| ONGLYZA(TM) (saxagliptin) With Metformin as Initial Combination Therapy ... - MarketWatch (press release) |
|
|
MarketWatch (press release)Patients with Renal Impairment: The dose of ONGLYZA is 2.5 mg once daily for patients with moderate or severe renal impairment, or with end-stage renal ...52-Week Study Finds ONGLYZA(TM) (saxagliptin) When Added To Metformin Was Non ... Trading Markets (press release)Bristol-Myers Squibb, AstraZeneca Announce Results Up To 76-weeks From Phase 3 ... read more |